Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine as adjuvant to ropivacaine for adductor canal block in knee arthroscopy
ChiCTR2200065236Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in acute postoperative pain (4 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Duration of sensory block. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2200065236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065236.